A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions
about
The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycleThe acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses.Viruses and human cancers: a long road of discovery of molecular paradigms.Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaChromatin at the intersection of viral infection and DNA damageA protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription.Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbitsHuman T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.Changing the ubiquitin landscape during viral manipulation of the DNA damage response.Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.The MYST family of histone acetyltransferases and their intimate links to cancer.Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animalsDiscovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4.HTLV-1 Rex: the courier of viral messages making use of the host vehicle.Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesisE3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60.The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.Adenovirus E4orf4 protein downregulates MYC expression through interaction with the PP2A-B55 subunit.Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels.HTLV-I p30: a versatile protein modulating virus replication and pathogenesis.The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30II and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma.Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells.
P2860
Q26864846-EECA7F56-1B16-4341-9AD1-3043030A458CQ28256824-40C51ACB-16BF-4636-8275-22594EB2193DQ30384388-0551A467-8BFE-4D45-96D0-E350AE5495D0Q33585243-59CD809D-0841-4AB8-BD5F-8188B103E499Q33729186-3B9652D2-A4DC-4424-9537-DCBB43271EB0Q34179693-9681E662-6EE8-45EA-BF67-89E3EF0D7D07Q34233092-70350146-696A-48CF-BC8A-A47259F50373Q34310872-BBD7DE78-D47D-4DBE-81FE-13928FD3D032Q34545731-D35080BF-696E-427C-88D1-8040E74A6DCFQ34605818-8F389330-9818-4DFC-B6C5-7DD72AB83BC0Q34606461-AA62C141-3A6F-4E84-868B-EE9CE7B5A8B0Q35071356-06729D1B-E86D-48B7-972D-BB2FF0E15720Q35261463-FD301E20-7B68-4793-A562-11E62A17FEBAQ35660314-7404E025-B34C-43A2-AA7D-CB6882575BB4Q35854193-18FDCD76-8307-40D2-B1A0-BB9FB771F2D1Q35920356-387213C7-9B60-4EB0-833A-C09FD951AF27Q36103218-0F991790-F580-4B9A-B3D2-35EF71916124Q36299426-A85EC4FF-A2B9-4B45-AFC4-F16663E63F6DQ36688522-9489B5B8-411A-44F4-8F56-4F3ACD9353D0Q36908407-B91F0BDB-8D74-48BD-9B71-B837569CE0B2Q37000992-4C73717B-E16A-4E5D-AE89-E404927C4052Q37145309-C31AB62B-E387-4565-8CF9-3F32E5BE556CQ37646720-597F240A-F26C-42C3-A7BF-855577805E7CQ38042924-5B5BA0C0-31A7-48C5-A3A3-4D5F6D78381DQ38068180-F941893F-1ED0-485D-B024-DB68FB6AEF09Q38847256-A85B6259-13BE-44DF-9A04-0A9758ACC589Q39850197-F87C9377-174B-4C1A-83BE-D6352896116DQ39957569-4FB1772C-BC32-4493-8746-5D4B0D8B20CEQ40018422-468A5109-D5AF-403A-9325-69E0A1E85A89Q41811371-A3B0181C-738F-43DF-8A63-445332D51306Q49806891-02151C8B-FA5C-406F-AFAF-CC786F0ADF56Q54205980-0AED123C-07D1-4B5E-8FF5-90276680EA6CQ54217632-A7483EC1-F740-4E48-8A3C-428CF19BDBEA
P2860
A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@ast
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@en
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@nl
type
label
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@ast
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@en
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@nl
prefLabel
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@ast
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@en
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@nl
P2093
P2860
P1476
A human T-cell lymphotropic vi ...... 0 transcriptional interactions
@en
P2093
Anima Sharma
Anne-Marie Girard
Bernhard Lüscher
Craig N Robson
Elizabeth F Matlock
Hideaki Tagami
Hirokuni Taguchi
Junyu Zhang
Kasuen Wong
Lowery Rogers
P2860
P304
P356
10.1128/MCB.25.14.6178-6198.2005
P407
P577
2005-07-01T00:00:00Z